Latest News
Immunic, Inc.
- Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
- Immunic presents data on vidofludimus calcium at MS conference
- Immunic, Inc. (IMUX) Reports New MS Data Supporting Vidofludimus Calcium
- Immunic Appoints Jaa Roberson as Chief People Officer
- Immunic appoints Jaa Roberson as Chief People O...
- Immunic Appoints Jaa Roberson as Chief People Officer Ahead of Phase 3 Results
- Immunic appoints Jaa Roberson as Chief People O...
- Immunic, Inc. (IMUX) Appoints Jaa Roberson as Chief People Officer
- Immunic, Inc. (IMUX) Appoints Chief People Officer
- Immunic Inc. (IMUX) Rises 4.35% to $6.95, Pressing Toward Upper End of Recent Range - Pairs Trade
- Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
- Immunic to present four abstracts on MS drug vi...
Headlines from the last 30 days, linking to the original publishers. See all market news →